Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
Recorded changes
86,510 on record
Recorded policy changes, newest first| Recorded | Payer | Policy | Change |
|---|
| May 25, 2026 | UnitedHealthcare | Chromosome Microarray Testing (Non-Oncology Conditions)PayerPolicy · UHC-EXCH-MD-CHROMOSOME-MICROARRAY-TESTING | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Chemotherapy Observation or Inpatient HospitalizationPayerPolicy · UHC-EXCH-MD-CHEMOTHERAPY-OBSERVATION-INPATIENT-HOSPITALIZATION | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Chelation TherapyPayerPolicy · UHC-EXCH-MD-CHELATION-THERAPY-NON-OVERLOAD-CONDITIONS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Cell-Free Fetal DNA TestingPayerPolicy · UHC-EXCH-MD-CELL-FREE-FETAL-DNA-TESTING | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Catheter Ablation for Atrial FibrillationPayerPolicy · UHC-EXCH-MD-CATHETER-ABLATION-ATRIAL-FIBRILLATION | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Category III CodesPayerPolicy · UHC-EXCH-MD-CATEGORY-III-CODES | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Carrier Testing Panels for Genetic DiseasesPayerPolicy · UHC-EXCH-MD-CARRIER-TESTING-FOR-GENETIC-DISEASES | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Cardiovascular Disease Risk TestsPayerPolicy · UHC-EXCH-MD-CARDIOVASCULAR-DISEASE-RISK-TESTS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Buprenorphine (Brixadi & Sublocade) – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-BUPRENORPHINE-IEX | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Brow Ptosis and Eyelid RepairPayerPolicy · UHC-EXCH-MD-BROW-PTOSIS-EYELID-REPAIR | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Bronchial ThermoplastyPayerPolicy · UHC-EXCH-MD-BRONCHIAL-THERMOPLASTY | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Briumvi (Ublituximab-Xiiy) – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-BRIUMVI-UBLITUXIMAB-XIIY-IEX | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Brineura (Cerliponase Alfa) – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-BRINEURA-CERLIPONASE-ALFA-IEX | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Breast Reduction SurgeryPayerPolicy · UHC-EXCH-MD-BREAST-REDUCTION-SURGERY | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Breast ReconstructionPayerPolicy · UHC-EXCH-MD-BREAST-RECONSTRUCTION | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Breast Imaging for Screening and Diagnosing CancerPayerPolicy · UHC-EXCH-MD-BREAST-IMAGING-SCREENING-DIAGNOSING-CANCER | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Botulinum Toxins A and B – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-BOTULINUM-TOXINS-A-B-IEX | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Benlysta (Belimumab) – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-BENLYSTA-BELIMUMAB-IEX | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Beds and MattressesPayerPolicy · UHC-EXCH-MD-BEDS-MATTRESSES | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Bariatric SurgeryPayerPolicy · UHC-EXCH-MD-BARIATRIC-SURGERY | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Autologous Cellular TherapyPayerPolicy · UHC-EXCH-MD-AUTOLOGOUS-CELLULAR-THERAPY | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | ApheresisPayerPolicy · UHC-EXCH-MD-APHERESIS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Antiemetics for Oncology – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-ANTIEMETICS-FOR-ONCOLOGY-INDIVIDUAL-EXCH-59C0C2CB1E | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Amondys 45 (Casimersen) – Commercial and Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-AMONDYS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Ambulance ServicesPayerPolicy · UHC-EXCH-MD-AMBULANCE-SERVICES | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Alpha1-Proteinase Inhibitors – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-ALPHA1-PROTEINASE-INHIBITORS-IEX | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Airway Clearance DevicesPayerPolicy · UHC-EXCH-MD-AIRWAY-CLEARANCE-DEVICES | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Adzynma (ADAMTS13, Recombinant-Krhn) – Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-ADZYNMA-ADAMTS13-RECOMBINANT-KRHN-INDIVI-C4A425DEA6 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Adakveo (Crizanlizumab-Tmca) – Commercial and Individual Exchange Medical Benefit Drug PolicyPayerPolicy · UHC-EXCH-MD-ADAKVEO-CRIZANLIZUMAB-TMCA | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Abnormal Uterine Bleeding and Uterine FibroidsPayerPolicy · UHC-EXCH-MD-ABNORMAL-UTERINE-BLEEDING-UTERINE-FIBROIDS | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Ablative Treatment for Spinal PainPayerPolicy · UHC-EXCH-MD-ABLATIVE-TREATMENT-SPINAL-PAIN | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Violence and AbusePayerPolicy · UHC-CG-VIOLENCE-AND-ABUSE-E4115AC83C | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Tumor-Infiltrating Lymphocyte (TIL) Cell TherapyPayerPolicy · UHC-CG-TUMOR-INFILTRATING-LYMPHOCYTE-TIL-CELL-THERAP-5D4F783ECB | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Tumor-Infiltrating Lymphocyte (TIL) Cell Therapy (for Ohio Only)PayerPolicy · UHC-CG-TUMOR-INFILTRATING-LYMPHOCYTE-TIL-CELL-THERAP-2C74DB4F1A | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Transplant Review Guidelines: Solid Organ TransplantationPayerPolicy · UHC-CG-TRANSPLANT-REVIEW-GUIDELINES-SOLID-ORGAN-TRAN-BB0E485C3F | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Transplant Review Guidelines: Solid Organ Transplantation (for Ohio Only)PayerPolicy · UHC-CG-TRANSPLANT-REVIEW-GUIDELINES-SOLID-ORGAN-TRAN-3B6A1D1302 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Transplant Review Guidelines: Hematopoietic Stem Cell TransplantationPayerPolicy · UHC-CG-TRANSPLANT-REVIEW-GUIDELINES-HEMATOPOIETIC-ST-6CC9508F35 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Transplant Review Guidelines: Hematopoietic Stem Cell Transplantation (for Ohio Only)PayerPolicy · UHC-CG-TRANSPLANT-REVIEW-GUIDELINES-HEMATOPOIETIC-ST-5543895301 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Transplant Review Guidelines: Hematopoietic Stem Cell Transplantation (for Ohio Only)PayerPolicy · UHC-CG-TRANSPLANT-REVIEW-GUIDELINES-HEMATOPOIETIC-ST-46B145FB4D | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Tobacco UsePayerPolicy · UHC-CG-TOBACCO-USE-04AF8D53D8 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | T-Cell Receptor T-Cell TherapyPayerPolicy · UHC-CG-T-CELL-RECEPTOR-T-CELL-THERAPY-E8C31A90C7 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | T-Cell Receptor T-Cell Therapy (for Ohio Only)PayerPolicy · UHC-CG-T-CELL-RECEPTOR-T-CELL-THERAPY-FOR-OHIO-ONLY-38BEBF52FB | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Special Health Care NeedsPayerPolicy · UHC-CG-SPECIAL-HEALTH-CARE-NEEDS-303DFA0ADE | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Sickle Cell DiseasePayerPolicy · UHC-CG-SICKLE-CELL-DISEASE-DA2927CDE8 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | SepsisPayerPolicy · UHC-CG-SEPSIS-3293AE5365 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Preventive ServicesPayerPolicy · UHC-CG-PREVENTIVE-SERVICES-88A8694C09 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Preventive Pediatric Health Care ScreeningPayerPolicy · UHC-CG-PREVENTIVE-PEDIATRIC-HEALTH-CARE-SCREENING-9816B6637E | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Physical ActivityPayerPolicy · UHC-CG-PHYSICAL-ACTIVITY-AAE378117F | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Persons with DisabilitiesPayerPolicy · UHC-CG-PERSONS-WITH-DISABILITIES-68BF124FC7 | New policy |
|---|
| May 25, 2026 | UnitedHealthcare | Perinatal CarePayerPolicy · UHC-CG-PERINATAL-CARE-AD6AF7486B | New policy |
|---|